Narsoplimab
Narsoplimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Narsoplimab is under investigation in clinical trial NCT03205995 (Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome).
| Trade Name | Narsoplimab |
| Generic | Narsoplimab |
| Narsoplimab Other Names | MASP-2 antibody, Narsoplimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Narsoplimab
